Canada markets closed

Psychemedics Corporation (PMD)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.5500-0.0700 (-2.67%)
At close: 04:00PM EDT
2.7600 +0.21 (+8.24%)
After hours: 06:15PM EDT

Psychemedics Corporation

5220 Spring Valley Road
Suite 230
Dallas, TX 75254
United States
800 527 7424
https://www.psychemedics.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees116

Key Executives

NameTitlePayExercisedYear Born
Mr. Brian HullingerPresident, CEO & Director361.37kN/A1968
Ms. Daniella MehalikVice President of Finance126.41kN/A1990
Ms. Shannon ShoemakerChief Revenue Officer187.82kN/AN/A
Dr. Werner A. Baumgartner Ph.D.FounderN/AN/AN/A
Ms. Annette BaumgartnerFounderN/AN/AN/A
Mr. Michael WeisenhoffPrincipal Financial & Accounting ManagerN/AN/A1990
Mr. Patrick J. Kinney Jr.SecretaryN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

Corporate Governance

Psychemedics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.